Attached files

file filename
8-K - FORM 8-K - MiddleBrook Pharmaceuticals, Inc.c03672e8vk.htm
Exhibit 99.1
UNITED STATES BANKRUPTCY COURT
DISTRICT OF DELAWARE
     
In re MiddleBrook Pharmaceuticals, Inc.
  Case No. 10-11485
        Debtor
  Reporting Period: June 1 — June 30, 2010
MONTHLY OPERATING REPORT
File with Court and submit copy to United States Trustee within 20 days after end of month
Submit copy of report to any official committee appointed in the case.
                 
        Document   Explanation   Affidavit/Supplement
REQUIRED DOCUMENTS   Form No.   Attached   Attached   Attached
Certifications
               
Schedule of Cash Receipts and Disbursements
  MOR-1   X        
Bank Reconciliation (or copies of debtor’s bank reconciliations)
          see certifications   X
Schedule of Professional Fees Paid
  MOR-1b   X        
Copies of bank statements
               
Cash disbursements journals
      X        
Statement of Operations
  MOR-2   X        
Balance Sheet
  MOR-3   X        
Status of Postpetition Taxes
          see certifications   X
Copies of IRS Form 6123 or payment receipt
               
Copies of tax returns filed during reporting period
               
Summary of Unpaid Postpetition Debts
  MOR-4   X        
Listing of aged accounts payable
  MOR-4   X        
Accounts Receivable Reconciliation and Aging
  MOR-5   X        
Debtor Questionnaire
  MOR-5   X        
I declare under penalty of perjury (28 U.S.C. Section 1746) that this report and the attached documents are true and correct to the best of my knowledge and belief.
         
 
Signature of Debtor
 
 
Date
   
 
       
 
Signature of Joint Debtor
 
 
Date
   
 
       
/s/ David Becker
  July 21, 2010    
 
Signature of Authorized Individual*
 
 
Date
   
 
       
David Becker
  EVP, CFO and Acting President and CEO    
 
Printed Name of Authorized Individual
 
 
Title of Authorized Individual
   
     
*   Authorized individual must be an officer, director or shareholder if debtor is a corporation; a partner if debtor is a partnership; a manager or member if debtor is a limited liability company.
MOR
(04/07)

 

 


 

UNITED STATES BANKRUPTCY COURT
DISTRICT OF DELAWARE
     
In re MiddleBrook Pharmaceuticals, Inc.
  Case No. 10-11485
        Debtor
  Reporting Period: June 1 — June 30, 2010
CERTIFICATIONS
A. Bank Reconciliation Certification
The undersigned verifies that, to my knowledge, all of the Debtors’ June 30, 2010 bank balances have been reconciled in an accurate and timely manner.
B. Post-petition Taxes Certification
The undersigned verifies that, to my knowledge, all post-petition tax obligations, including but not limited to payroll, real property, income, franchise and other taxes have been paid to the proper taxing authority when due.
         
/s/ David Becker
  July 21, 2010    
 
Signature of Authorized Individual
 
 
Date
   
 
       
David Becker
  EVP, CFO and Acting President and CEO    
 
Printed Name of Authorized Individual
 
 
Title of Authorized Individual
   

 

 


 

     
In re: MiddleBrook Pharmaceuticals, Inc.
  Case No. 10-11485
        Debtor
  Reporting Period: June 1 — 30, 2010
MOR 1
                                 
    Current Month     Cumulative Filing to Date  
    Actual     Forecast     Actual     Forecast  
 
                               
Beginning Date
  1-Jun-10   1-Jun-10   3-May-10   3-May-10
Ending Date
  30-Jun-10   30-Jun-10   30-Jun-10   30-Jun-10
 
                               
Cash — Beginning Balance
  $ 4,995,640     $ 5,020,387     $ 5,257,718     $ 5,269,539  
 
                               
Receipts
                               
Lockbox
  $ 178,957     $ 100,809     $ 261,392     $ 228,359  
Misc Deposit
  $ 27,001             $ 63,568          
 
                       
Total Receipts
  $ 205,958     $ 100,809     $ 324,961     $ 228,359  
 
                               
Operating Disbursements
                               
Broadpoint
  $ 0     $ 0     $ 0     $ 0  
Cardinal Co-Pay Redemptions
  $ 0     $ 0     $ 0     $ 0  
Dr Directory
  $ 0     $ 0     $ 0     $ (49,826 )
Legal & Deal fees
  $ 0     $ 0     $ 0     $ 0  
Payroll
  $ (215,391 )   $ (363,896 )   $ (476,300 )   $ (620,667 )
Severance
  $ 0     $ 0     $ 0     $ 0  
Vacation Payout
  $ 0     $ 0     $ 0     $ 0  
Invoices in A/P Aging
  $ (614,475 )   $ (666,870 )   $ (697,725 )   $ (761,902 )
Misc (TX rent, Insurance, ICS)
  $ (33,373 )   $ (33,500 )   $ (66,746 )   $ (63,500 )
Other
  $ (2,168 )   $ 0     $ (5,716 )   $ (150,000 )
 
                       
Total Operating Disbursements
  $ (865,406 )   $ (1,064,266 )   $ (1,246,487 )   $ (1,645,895 )
 
                       
 
                               
Net Operating Cash Flow
  $ (659,448 )   $ (963,457 )   $ (921,526 )   $ (1,417,536 )
 
                       
 
                               
Non-Operating Disbursements
                               
Capex
                               
Professional Fees
                               
 
                       
Total Non-Operating Disbursements
  $ 0     $ 0     $ 0     $ 0  
 
                       
 
                               
Net Operating Cash Flow Before Financing
  $ (659,448 )   $ (963,457 )   $ (921,526 )   $ (1,417,536 )
 
                       
 
                               
Financing Activities
                               
Interest Payments
                               
 
                       
Financing Activities
  $ 0     $ 0     $ 0     $ 0  
 
                               
Cash Flow
  $ (659,448 )   $ (963,457 )   $ (921,526 )   $ (1,417,536 )
 
                       
 
                               
Ending Cash Balance (per books)
  $ 4,336,192     $ 4,056,929     $ 4,336,192     $ 3,852,003  
 
                       
         
       
DISBURSEMENTS FOR CALCULATING U.S. TRUSTEE QUARTERLY FEES: (FROM CURRENT MONTH ACTUAL COLUMN)        
TOTAL DISBURSEMENTS
  $ (865,406 )
LESS: TRANSFERS TO DEBTOR IN POSSESSION ACCOUNTS
    0  
PLUS: ESTATE DISBURSEMENTS MADE BY OUTSIDE SOURCES (i.e. from escrow accounts)
    0  
TOTAL DISBURSEMENTS FOR CALCULATING U.S. TRUSTEE QUARTERLY FEES
  $ (865,406 )

 

 


 

     
In re: MiddleBrook Pharmaceuticals, Inc.
  Case No. 10-11485
         Debtor
  Reporting Period: June 1 — 30, 2010
Disbursements Journal
Checks cut during period
                         
GL Posting       Checkbook     CM Trx        
Date   Source Document   Amount     Number   Voided   Paid ToRcvd From
6/1/2010
  PMCHK   $ 3,368.95     2529   No   ExecuSuites I-270, Inc.
6/1/2010
  PMCHK   $ 1,025.45     2530   No   IKON Financial Services Box 650016
6/1/2010
  PMCHK   $ 39.41     2531   No   Maryland
6/1/2010
  PMCHK   $ 477.91     2532   No   NYS EPIC PROGRAM
6/9/2010
  PMCHK   $ 1,690.52     2533   No   Commonwealth of PA/DRP
6/9/2010
  PMCHK   $ 1,392.26     2534   No   CONNECTICUT MEDICAL ASSITANCE PROGRAM
6/9/2010
  PMCHK   $ 29.39     2535   No   D.C. Treasurer Med Asst Admin
6/9/2010
  PMCHK   $ 441.89     2536   No   Georgia DCH, Dept. of Medical Assist
6/9/2010
  PMCHK   $ 114.01     2537   No   Department of Med Asst Srvc
6/9/2010
  PMCHK   $ 105.42     2538   No   DHS
6/9/2010
  PMCHK   $ 280.69     2539   No   The Division of Hlth Care Financing
6/9/2010
  PMCHK   $ 48,532.83     2540   No   Health & Human Srvc Comm.
6/9/2010
  PMCHK   $ 437.94     2541   No   Kentucky State Treasurer
6/9/2010
  PMCHK   $ 19,212.24     2542   No   Louisiana Dept of Health&Hospitals
6/9/2010
  PMCHK   $ 13.72     2543   No   Maryland
6/9/2010
  PMCHK   $ 43.69     2544   No   State of Maryland
6/9/2010
  PMCHK   $ 6,404.90     2545   No   North Carolina XIX Drug Rebate
6/9/2010
  PMCHK   $ 45,018.51     2546   No   NYS Department of Health
6/9/2010
  PMCHK   $ 807.82     2547   No   South Carolina Dept fo H&H Srvc.
6/9/2010
  PMCHK   $ 116.25     2548   No   State of Alaska Dept of Hlth&SS
6/9/2010
  PMCHK   $ 39.19     2549   No   State of Montana-Medicaid Rebate
6/9/2010
  PMCHK   $ 40.69     2550   No   State of Michigan
6/9/2010
  PMCHK   $ 49.57     2551   No   Treasurer,St of New Hampshire
6/9/2010
  PMCHK   $ 138.73     2552   No   Treasurer St of Colorado
6/9/2010
  PMCHK   $ 29.39     2553   No   Treasurer of the State Ohio
6/9/2010
  PMCHK   $ 79.60     2554   No   ADP Commercial Leasing
6/9/2010
  PMCHK   $ 99.43     2555   No   AT Conference
6/9/2010
  PMCHK   $ 423.80     2557   No   RMA Chauffeured Transportation
6/9/2010
  PMCHK   $ 97,826.21     2558   No   United Healthcare Insurance Co.
6/9/2010
  PMCHK   $ 2,035.92     2559   No   UNUM Life Insurance
6/9/2010
  PMCHK   $ 2,269.45     2560   No   VSP — (AT)
6/9/2010
  PMCHK   $ 795.72     2561   No   Vista Imaging Supplies
6/9/2010
  PMCHK   $ 150.00     2562   No   WebEx Communications Inc.
6/9/2010
  PMCHK   $ 250.76     2563   No   WorldWide express
6/9/2010
  PMCHK   $ 1,071.09     2564   No   AT&T Mobility
6/9/2010
  PMCHK   $ 500.00     2565   No   Robin N. Belsaas
6/9/2010
  PMCHK   $ 69.42     2566   No   AT&T
6/9/2010
  PMCHK   $ 318.45     2567   No   Gary Herman
6/9/2010
  PMCHK   $ 150.00     2568   No   Ohio State Bd of Pharmacy
6/9/2010
  PMCHK   $ 24,456.33     2569   No   Integrated Commercialization Sol.
6/9/2010
  PMCHK   $ 1,066.33     2570   No   State of Mississippi Div of Medicaid
6/9/2010
  PMCHK   $ 1,793.73     2571   No   Indiana Medicaid Drug Rebates-
6/9/2010
  PMCHK   $ 47.03     2572   No   State of Wyoming
6/9/2010
  PMCHK   $ 1,334.49     2573   No   Oklahoma Health Care Authority
6/9/2010
  PMCHK   $ 19.60     2574   No   Alabama Medicaid Agency
6/9/2010
  PMCHK   $ 6.67     2575   No   Washington Dept of Revenue
6/9/2010
  PMCHK   $ 523.91     2576   No   Lynne B. Marton
6/9/2010
  PMCHK   $ 951.98     2577   No   ATT
6/10/2010
  PMCHK   $ 50.00     2578   No   NYS Sales Tax Processing
6/10/2010
  PMCHK   $ 257.89     2579   No   Utah State Dept of Health
6/10/2010
  PMCHK   $ 74.71     2580   No   Amber Tomlinson
6/10/2010
  PMCHK   $ 8,119.40     2581   No   Brad Cole

 

 


 

                         
GL Posting       Checkbook     CM Trx        
Date   Source Document   Amount     Number   Voided   Paid ToRcvd From
6/10/2010
  PMCHK   $ 2,260.35     2582   No   David Becker
6/10/2010
  PMCHK   $ 231.02     2583   No   Marcus Schestopol
6/21/2010
  PMCHK   $ 1,100.00     2584   No   American Stock Transfer & Trust Co
6/21/2010
  PMCHK   $ 154.81     2585   No   Arkansas Dept of Hlth&Human
6/21/2010
  PMCHK   $ 991.17     2586   No   Avaya, inc.
6/21/2010
  PMCHK   $ 16.59     2587   No   Broadridge
6/21/2010
  PMCHK   $ 566.00     2588   No   Carella, Byrne, Bain
6/21/2010
  PMCHK   $ 68.94     2589   No   Catalent Pharma Solutions
6/21/2010
  PMCHK   $ 232.79     2590   No   Corporation Service Company
6/21/2010
  PMCHK   $ 30,780.00     2591   No   Dakota Drug Inc.
6/21/2010
  PMCHK   $ 238.75     2592   No   Department of Social & Hlth Srvc
6/21/2010
  PMCHK   $ 783.80     2593   No   Sheila Filipponi
6/21/2010
  PMCHK   $ 650.89     2594   No   Missouri Healthnet Division
6/21/2010
  PMCHK   $ 16,650.94     2595   No   PPD Medical Communications
6/21/2010
  PMCHK   $ 47,893.98     2596   No   QPharma Corp
6/21/2010
  PMCHK   $ 24.38     2597   No   State of Rhode Island
6/21/2010
  PMCHK   $ 750.00     2598   No   SunTrust
6/21/2010
  PMCHK   $ 234.53     2599   No   TechDepot
6/21/2010
  PMCHK   $ 4,033.00     2600   No   Travelers
6/21/2010
  PMCHK   $ 1,206.77     2601   No   Dr. Donald J. Treacy
6/21/2010
  PMCHK   $ 7,831.46     2602   No   Wisconsin Dept of Health
6/21/2010
  PMCHK   $ 181.75     2603   No   WorldWide express
6/28/2010
  PMCHK   $ 250.00     5011   No   NH Board of Pharmacy
6/29/2010
  PMCHK   $ 671.94     5012   No   David Becker
6/29/2010
  PMCHK   $ 999.19     5013   No   Robin N. Belsaas
6/29/2010
  PMCHK   $ 1,944.23     5014   No   Brad Cole
6/29/2010
  PMCHK   $ 1,045.53     5015   No   Nicholas Garito
6/29/2010
  PMCHK   $ 855.06     5016   No   Gary Herman
6/29/2010
  PMCHK   $ 918.40     5017   No   Cynthia Tirpak
6/29/2010
  PMCHK   $ 73.32     5018   No   Amber Tomlinson
6/29/2010
  PMCHK   $ 939.40     5019   No   Dr. Donald J. Treacy
 
      $ 399,172.28     Checks Cut        
Debits to bank other than checks
                                 
Transaction               Bank     Customer      
Date   Description   Amount     Ref. #     Ref. #     Payee / Description
6/1/2010
  ACH DEBIT     6,320.76       10277       0     AMERICAN UNITED PENSION (401K)
6/1/2010
  WIRE TRSF DEBIT FX     204,712.52       1360       0     Sandoz — FX 814628 EUR165692.04 1.235500
6/15/2010
  WIRE TRANSFER DEBIT     10,000.00       3881       0     PPD DEVELOPMENT LP
6/4/2010
  ACH DEBIT     341.72       2078       0     ADP PAYROLL FEES ADP — FEES
6/16/2010
  ACH DEBIT     7,070.76       1028       0     AMERICAN UNITED PENSIONPMT (401K)
6/18/2010
  ACH DEBIT     766.46       2212       0     ADP PAYROLL FEES ADP — FEES
6/21/2010
  ACH DEBIT     589.89       1892       0     The Utility Company (IT related)
6/25/2010
  ACH DEBIT     122.59       1318       0     ADP PAYROLL FEES ADP — FEES
6/25/2010
  ACH DEBIT     67.65       2139       0     ADP PAYROLL FEES ADP — FEES
6/28/2010
  SERVICE CHARGE     657.18       13307       0     ANALYSIS SERVICE CHARGE (bank charge)
6/30/2010
  ACH DEBIT     7,070.76       757       0     AMERICAN UNITED PENSIONPMT (401K)
6/11/2010
  WIRE TRANSFER DEBIT     64,520.96       2643       0     ADP TAX SVCS INC. REV. (payroll related)
6/14/2010
  WIRE TRANSFER DEBIT     33,029.04       2775       0     ADP INC FUNDSMGMT (payroll-related)
6/28/2010
  WIRE TRANSFER DEBIT     64,800.31       3015       0     ADP TAX SVCS INC. REV. (payroll related)
6/29/2010
  WIRE TRANSFER DEBIT     32,578.57       2457       0     ADP INC FUNDSMGMT (payroll-related)
6/28/2010
  ACH DEBIT     212.14                     Check stock order — Capital One Bank
6/28/2010
  WIRE TRANSFER DEBIT     33,372.85       W06282010             Maguire Partners — Texas rent
 
                             
        $ 466,234.16     Debits to Bank other than Checks
 
                             
 
                               
        $ 865,406.44     total disbursements
 
                             

 

 


 

                                 
GL Posting       Checkbook     CM Trx            
Date   Source Document   Amount     Number     Voided     Paid ToRcvd From
Checks cleared by bank:                    
6/1/2010
  DEBIT MEMO     447.71       16     0       CONTROL DISBURSEMENT
6/2/2010
  DEBIT MEMO     4,935.00       15     0       CONTROL DISBURSEMENT
6/3/2010
  DEBIT MEMO     4,444.33       14     0       CONTROL DISBURSEMENT
6/4/2010
  DEBIT MEMO     383.82       40     0       CONTROL DISBURSEMENT
6/7/2010
  DEBIT MEMO     4,161.90       10     0       CONTROL DISBURSEMENT
6/8/2010
  DEBIT MEMO     1,750.40       24     0       CONTROL DISBURSEMENT
6/9/2010
  DEBIT MEMO     1,785.59       11     0       CONTROL DISBURSEMENT
6/10/2010
  DEBIT MEMO     4,046.86       23     0       CONTROL DISBURSEMENT
6/11/2010
  DEBIT MEMO     50       34     0       CONTROL DISBURSEMENT
6/14/2010
  DEBIT MEMO     114.12       58     0       CONTROL DISBURSEMENT
6/15/2010
  DEBIT MEMO     8,175.91       248     0       CONTROL DISBURSEMENT
6/16/2010
  DEBIT MEMO     29,987.62       33     0       CONTROL DISBURSEMENT
6/17/2010
  DEBIT MEMO     176,202.97       7     0       CONTROL DISBURSEMENT
6/18/2010
  DEBIT MEMO     11,468.93       13     0       CONTROL DISBURSEMENT
6/21/2010
  DEBIT MEMO     171.42       81     0       CONTROL DISBURSEMENT
6/23/2010
  DEBIT MEMO     507.54       17     0       CONTROL DISBURSEMENT
6/24/2010
  DEBIT MEMO     257.89       28     0       CONTROL DISBURSEMENT
6/25/2010
  DEBIT MEMO     45,065.54       57     0       CONTROL DISBURSEMENT
6/28/2010
  DEBIT MEMO     18,159.44       43     0       CONTROL DISBURSEMENT
6/29/2010
  DEBIT MEMO     84,498.68       43     0       CONTROL DISBURSEMENT
6/30/2010
  DEBIT MEMO     9,698.05       63     0       CONTROL DISBURSEMENT
 
                             
 
      $ 406,313.72                      
 
                             

 

 


 

     
In re: MiddleBrook Pharmaceuticals, Inc.
  Case No. 10-11485
         Debtor
  Reporting Period: June 1 — 30, 2010
SCHEDULE OF PROFESSIONAL FEES AND EXPENSES PAID
This schedule is to include all retained professional payments from case inception to current month
                                                                         
            Amount             Check     Amount Paid     Year-To-Date  
Payee   Period Covered     Approved     Payor     Number     Date     Fees     Expenses     Fees     Expenses  
none in May or June
                                                                       

 

 


 

     
In re: MiddleBrook Pharmaceuticals, Inc.
  Case No. 10-11485
         Debtor
  Reporting Period: June 1 — 30, 2010
                 
    June     Cumulative  
    2010     Filing to Date  
Gross Sales
    111,938       365,041  
Sales Reserves and Allowances
    471,126       519,052  
 
           
Net Revenue
    583,064       884,093  
 
               
Cost of Goods Sold
    581,284       994,268  
 
               
Salaries, Bonus & Temp Labor
    222,773       465,646  
Benefits, Payroll Taxes, Recruiting & Relocation
    79,256       95,426  
 
           
Subtotal: Salaries & Benefits
    302,029       561,072  
 
               
Stock-Based Compensation
    448,443       408,171  
Marketing & Advertising
    1,051       1,897  
Travel & Entertainment
    20,131       36,108  
Facilities and Equipment Related
    58,718       108,644  
Insurance
    76,623       160,715  
Distribution Expense
    124,016       223,513  
Office & General Lab Supplies
    3,035       4,235  
Consulting & Legal Fees
    897,637       1,641,200  
Patents & Licensing
    121,356       217,942  
Audit, IR & Financial Fees
    7,561       31,248  
Non-Income Taxes
    232       1,305  
Depreciation and Amortization
    221,836       593,111  
Director and SAB Fees
    16,560       37,476  
 
           
 
               
Subtotal: FTE Expenses
    2,299,227       4,026,638  
 
           
 
               
Marketing Costs
    85,378       134,548  
Direct Project Costs
    2,867       117,573  
 
           
Total Expenses
    2,968,756       5,273,027  
 
           
Income (Loss) from Operations
    (2,385,693 )     (4,388,934 )
 
               
Interest Income
    0       199  
Other income (expense)
    0       2,905  
 
           
Net Income (Loss) Before Taxes
    (2,385,693 )     (4,385,830 )
 
           
 
               
Net Income (Loss)
    (2,385,693 )     (4,385,830 )
 
           

 

 


 

     
In re: MiddleBrook Pharmaceuticals, Inc.
  Case No. 10-11485
         Debtor
  Reporting Period: June 1 — 30, 2010
                 
    Current     Petition  
    Month     Date  
Cash & Cash Equivalents
    4,336,192       5,257,718  
Accounts Receivable, net
    (29,218 )     (490,487 )
Inventory
    1,764,996       2,213,158  
Prepaid and Other Current Assets
    3,579,537       3,397,106  
 
               
Property and Equipment
    11,108,162       14,341,773  
Accumulated Depreciation
    (9,444,034 )     (12,460,925 )
 
           
Property and Equipment, net
    1,664,129       1,880,848  
 
               
Deposits and Other Assets
    670,270       680,580  
 
               
Intangible Assets
    11,877,529       11,877,529  
Accum. Amort — Intangibles
    (3,062,960 )     (2,643,218 )
 
           
Intangible Assets, net
    8,814,569       9,234,311  
 
               
Total Assets
    20,800,475       22,173,234  
 
               
20000 - Accounts Payable — post-petition
    (524,441 )      
21201 - Accrued Payable to Lilly
    (6,155 )      
21210 - Accrued Professional Fees
    (1,294,008 )      
21250 - Accrued R&D Costs
    (3,047 )      
21275 - Accrued Keflex Copay Assistance
    (285 )      
21276 - Accrued Moxatag Copay Assistance
    (15,836 )      
21281 - Accrued Medicaid Rebates Payable
    (12,073 )      
21282 - Accrued Returns
    (21,902 )      
21290 - Other Accrued Expenses
    (203,345 )      
23200 - Wages Payable
    (36,440 )      
23650 - Employee Benefits — Flex Spending
    (2,468 )      
 
           
Accounts Payable and Accrued Expenses — Post-Petition
    (2,120,001 )      
 
               
20000 - Accounts Payable — pre-petion
    (3,094,822 )     (1,214,588 )
21110 - Accrued Severance
    (257,343 )     (281,258 )
21201 - Accrued Payable to Lilly
    (5,252 )     (5,252 )
21210 - Accrued Professional Fees
    (29,917 )     (199,917 )
21250 - Accrued R&D Costs
    (136,067 )     (136,067 )
21275 - Accrued Keflex Copay Assistance
    (5,329 )     (9,276 )
21276 - Accrued Moxatag Copay Assistance
    (2,942,645 )     (3,705,035 )
21281 - Accrued Medicaid Rebates Payable
    (417,759 )     (563,001 )
21282 - Accrued Returns
    (1,909,382 )     (1,945,797 )
21290 - Other Accrued Expenses
    (41,460 )     (292,773 )
23200 - Wages Payable
    (306,521 )     (306,521 )
23620 - Employee Benefits Pay-401k
          (33,339 )
23650 - Employee Benefits — Flex Spending
    (9,372 )     (3,899 )
25000 - Other Current Liabilities
    (4,835,277 )     (4,810,772 )
 
           
Accounts Payable and Accrued Expenses — Pre-Petition
    (13,991,148 )     (13,507,496 )
 
               
Deferred Contract Revenue — non-current (pre-petition)
    (11,625,000 )     (11,625,000 )
Deferred Lease Expense
    (19,587 )     (18,340 )
 
               
Common Stock
    (865,119 )     (865,119 )
Additional Paid in Capital
    (312,689,529 )     (312,281,358 )
 
               
Retained Earnings
    299,240,744       299,240,744  
YTD P&L
    21,269,166       16,883,336  
 
           
Accumulated Deficit
    320,509,910       316,124,080  
 
           
 
               
Stockholders’ Equity
    6,955,261       2,977,602  
 
               
Liabilities & Stockholders’ Equity
    (20,800,475 )     (22,173,234 )

 

 


 

     
In re: MiddleBrook Pharmaceuticals, Inc.
  Case No. 10-11485
         Debtor
  Reporting Period: June 1 — 30, 2010
         
Other Post-petition liabilities        
Professional bankruptcy fees — creditors’ committee cousel & FA
    594,090.74  
Professional bankruptcy fees — equity committee counsel
    300,000.00  
Professional bankruptcy fees — corporate and local counsel
    218,257.87  
Professional bankruptcy fees — KCC estimate
    28,500.00  
Professional legal fees (May & June)
    93,468.05  
DoctorDirectory (June estimate)
    44,089.26  
PPD estimate
    17,000.00  
Other miscellaneous May & June accruals — no invoices yet
    201,946.55  
 
     
 
       
 
  $ 1,497,352  
 
     

 

 


 

     
In re: MiddleBrook Pharmaceuticals, Inc.
  Case No. 10-11485
         Debtor
  Reporting Period: June 1 — 30, 2010
SUMMARY OF UNPAID POSTPETITION DEBTS
Attach aged listing of accounts payable.
                                                 
    Number of Days Past Due  
    Current     0-30     31-60     61-90     Over 90     Total  
Accounts Payable
    198,199.76       5,449.58                         203,649.34  
Wages Payable (401k contributions)
                                   
Taxes Payable (payroll-related taxes)
                                   
Rent/Leases-Building
                                   
Rent/Leases-Equipment
                                   
Secured Debt/Adequate Protection Payments
                                   
Professional Fees
    318,481.28       2,310.20                         320,791.48  
Amounts Due to Insiders*
                                   
Other:__________________________
                                   
Other:__________________________
                                   
Total Postpetition Debts
    516,681.04       7,759.78                         524,440.82  
Explain how and when the Debtor intends to pay any past-due postpetition debts.
All amounts in 0 — 30 days past due were paid in early July, just beyond the due date.
     
*   “Insider” is defined in 11 U.S.C. Section 101(31).
FORM MOR-4
(04/07)

 

 


 

     
In re: MiddleBrook Pharmaceuticals, Inc.
  Case No. 10-11485
         Debtor
  Reporting Period: June 1 — 30, 2010
SUMMARY OF UNPAID POSTPETITION DEBTS
                                             
        Voucher             Current Trx                
Vendor ID   Vendor Name   Number     Document Date     Amount     Document Number   Document Type   Paid Date  
ADP001
  ADP     038287       6/11/2010     $ 2,894.02     443202   Invoice     7/1/2010  
ALS002
  Alston & Bird LLP     038357       7/14/2010     $ 204,155.20     May 2010 80%   Invoice        
ALS002
  Alston & Bird LLP     038358       7/14/2010     $ 51,038.80     May 2010 20%   Invoice        
ALS002
  Alston & Bird LLP     038359       7/14/2010     $ 5,825.95     May 2010 Exps   Invoice        
ATC003
  AT Conference     038335       6/30/2010     $ 16.98     1788830610   Invoice        
ATT011
  AT&T Mobility     038344       6/29/2010     $ 832.89     836833917X07082010   Invoice        
ATT013
  A T & T 8174909174/8174908790     038337       6/27/2010     $ 77.52     8174908790 062010   Invoice        
ATT013
  A T & T 8174909174/8174908790     038340       6/27/2010     $ 354.20     8174909174 062010   Invoice        
ATT013
  A T & T 8174909174/8174908790     038341       6/27/2010     $ 1,043.44     8310001262 062010   Invoice        
ATT013
  A T & T 8174909174/8174908790     038343       6/29/2010     $ 1,290.15     8178371200 062010   Invoice        
BOW001
  Bowne of New York City     038318       6/23/2010     $ 1,342.40     I100641420   Invoice     7/1/2010  
CSC003
  Corporation Service Company     038297       5/7/2010     $ 53.25     52938683   Invoice     7/1/2010  
DCT002
  D.C. Treasurer Med Asst Admin     038286       5/31/2010     $ 2,500.00     FILING FEE 2009   Invoice     7/1/2010  
DEP008
  Department of Health Services     038300       6/7/2010     $ 37.23     1104220101   Invoice     7/1/2010  
DOC002
  DoctorDirectory.Com, Inc.     038317       6/29/2010     $ 58,454.19     4861   Invoice     7/1/2010  
EXC003
  Excel Micro     038342       7/8/2010     $ 120.00     0097746   Invoice        
EXC003
  Excel Micro     038333       6/8/2010     $ 63.00     0094777   Invoice     7/7/2010  
FLE001
  FlexAmerica, Inc.     038367       6/28/2010     $ 200.00     25707   Invoice        
FRA007
  Franchise Tax Board - CA     038293       6/15/2010     $ 34.98     3169462   Invoice     7/1/2010  
HEA012
  Healthcare & Family Services     037619       3/9/2010     $ (145.27 )   1104220094   Credit Memo        
ICS001
  Integrated Commercialization Sol.     038346       7/6/2010     $ 24,962.99     15110012950   Invoice        
IKO005
  IKON Finacial Services     038291       6/15/2010     $ 202.18     82336798   Invoice     7/1/2010  
IKO005
  IKON Finacial Services     038290       6/15/2010     $ 292.28     82367227   Invoice     7/1/2010  
IRO001
  Iron Mountain     038218       5/31/2010     $ 156.12     BYT1429   Invoice     7/1/2010  
KUR001
  Kurtzman Carson Consultants     038282       6/15/2010     $ 57,461.33     05312010   Invoice        
KUR001
  Kurtzman Carson Consultants     038283       5/25/2010     $ 2,310.20     USKCC310005   Invoice     7/1/2010  
MAR018
  Lynne B. Marton     038365       7/1/2010     $ 656.25     MB070110   Invoice        
MIS003
  Mississippi State Tax Commission     038284       5/25/2010     $ 72.45     287112 DEC 2008   Invoice     7/1/2010  
PIC003
  Picture This Communications, Inc.     038320       6/23/2010     $ 885.00     1517   Invoice     7/1/2010  
PRO011
  Prostar Services, Inc.     038305       6/24/2010     $ 45.36     348547   Invoice     7/1/2010  
PUR001
  Pure Compliance     038131       5/19/2010     $ 3,477.00     C01315   Invoice     7/1/2010  
PUR001
  Pure Compliance     038298       6/22/2010     $ 765.00     C02661   Invoice     7/1/2010  
QPH001
  QPharma Corp     038334       6/30/2010     $ 99,052.64     20968   Invoice        
RXS001
  RX Sample Solution     038368       7/12/2010     $ 612.50     54943   Invoice        
SHR003
  Shred-it USA, DBA Shred-it Dallas     038261       6/17/2010     $ 50.00     3737505657   Invoice        
STA011
  State of New Jersey Div     038296       5/4/2010     $ 881.49     522208264 2009   Invoice     7/1/2010  
TRA006
  Transport Solutions Inc     038285       5/31/2010     $ 250.00     8100028   Invoice     7/1/2010  
VER004
  Verizon     038312       6/28/2010     $ 903.85     6433957631   Invoice     7/1/2010  
VER010
  Verizon Business     038339       6/26/2010     $ 45.93     148901006   Invoice        
WEB001
  WebEx Communications Inc.     038338       6/23/2010     $ 150.00     3542277   Invoice        
WES008
  West Virginia State Tax Dept     038295       5/4/2010     $ 765.39     L1118294784   Invoice     7/1/2010  
WOR005
  WorldWide express     038345       6/29/2010     $ 91.91     986788   Invoice        
WOR005
  WorldWide express     038288       6/2/2010     $ 11.08     945924   Invoice     7/1/2010  
WOR005
  WorldWide express     038292       6/15/2010     $ 45.56     959602   Invoice     7/1/2010  
WOR005
  WorldWide express     038289       6/16/2010     $ 105.38     972987   Invoice     7/1/2010  
 
                                         
 
                                           
 
                      $ 524,440.82                  
 
                                         

 

 


 

     
In re: MiddleBrook Pharmaceuticals, Inc.
  Case No. 10-11485
         Debtor
  Reporting Period: June 1 — 30, 2010
ACCOUNTS RECEIVABLE RECONCILIATION AND AGING
                 
Accounts Receivable Reconciliation   Amount          
Total Accounts Receivable at the beginning of the reporting period
    605,932.48          
+ Amounts billed during the period
    111,937.73          
- Amounts collected during the period
    (178,957.37 )        
- Other adjustments during period
    (18,146.94 )        
Total Accounts Receivable at the end of the reporting period
    520,765.90          
                 
Accounts Receivable Aging   Amount          
0 - 30 days old
    112,029.21          
31 - 60 days old
    169,435.18          
61 - 90 days old
    235,261.08          
91+ days old
    3,866.08          
Total Accounts Receivable
    520,591.55          
Amount considered uncollectible (Bad Debt)
             
Accounts Receivable (Net)
    520,591.55       174.35  
 
          reconciling item  
DEBTOR QUESTIONNAIRE
         
Must be completed each month   Yes   No
1. Have any assets been sold or transferred outside the normal course of business this reporting period? If yes, provide an explanation below.
      X
2. Have any funds been disbursed from any account other than a debtor in possession account this reporting period? If yes, provide an explanation below.
      X
3. Have all postpetition tax returns been timely filed? If no, provide an explanation below.
  X    
4. Are workers compensation, general liability and other necessary insurance coverages in effect? If no, provide an explanation below.
  X    
5. Has any bank account been opened during the reporting period? If yes, provide documentation identifying the opened account(s). If an investment account has been opened provide the required documentation pursuant to the Delaware Local Rule 4001-3.
  X    
We created new accounts at Capital One Bank in June and previously provided the account numbers.
FORM MOR-5
(04/07)